Pivotal bioVenture Partners is a venture capital that is interested in life sciences. The firm was founded in 2017 and operates from San Francisco, although they support businesses in North America as well as Europe.
Focusing on companies that create innovative therapeutic products and platforms to battle against unmet medical issues is what Pivotal bioVenture Partners is interested in. Pivotal bioVenture Partners is interested in companies that provide and develop molecules for disease-causing modalities, pharmaceuticals, biotechnologies, and treatments for schizophrenia.
Biotechnology company using alpha particle emitting medical isotopes in targeted radiotherapy for cancer.
An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
Bolt Biotherapeutics is developing its novel BoltbodyTM platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).
Entasis Therapeutics is a Waltham, Massachusetts-based company.